CoronaryAtlas logo
CoronaryAtlas
Soluble urokinase plasminogen activator receptor
Pathway / Plaque inflammation

Soluble urokinase plasminogen activator receptor

PLAURprotein

suPAR amplifies leukocyte recruitment and vascular inflammation, exacerbating plaque destabilization and coronary thrombosis.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleImmune activation and leukocyte recruitment marker; predicts adverse outcomes in acute coronary syndrome.
Also acts inPlatelet activation, Coagulation / thrombus, Systemic / off-pathway
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000011422

Type I vs Type II discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
63
C — confounder / Type-II
76
A — assay feasibility
68
E — evidence strength
30
T1DI (composite)
9
Specificity differential (R−C)-12.4
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(6)